Artiva Biotherapeutics (ARTV) Times Interest Earned (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Times Interest Earned of -$2.09 for Q1 2026, down 55.98% year-over-year from -$4.75 in Q1 2025, and up 96.07% quarter-over-quarter from -$53.23 in Q4 2025.
Artiva Biotherapeutics (ARTV) Times Interest Earned (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Times Interest Earned for 4 consecutive years, with -$2.09 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned fell 55.98% year-over-year to -$2.09; the TTM figure through Mar 2026 stood at -$7.88 (down 73.86% YoY), while the FY2025 annual figure was -$23.15, down 144.94% from the prior year.
- Times Interest Earned improved to -$2.09 in Q1 2026 per ARTV's latest filing, from -$53.23 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$1.06 in Q3 2024 and bottomed at -$55.93 in Q4 2023.
- Historically, Times Interest Earned has averaged -$14.6 across 4 years, with a median of -$2.09 in 2026.
- Annual changes were most pronounced in 2024 — Times Interest Earned jumped 95.41% — and 2025, when it plunged 1974.3%.
- Artiva Biotherapeutics' Times Interest Earned stood at -$55.93 in 2023, then surged by 95.41% to -$2.57 in 2024, then slumped by 1974.3% to -$53.23 in 2025, then jumped by 96.07% to -$2.09 in 2026.
- Business Quant data shows ARTV's Times Interest Earned at -$2.09 in Q1 2026, -$53.23 in Q4 2025, and -$12.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | -2.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.42 |
| Mar 31, 2026 | -2.09 |
| Dec 31, 2025 | -53.23 |
| Sep 30, 2025 | -12.45 |
| Jun 30, 2025 | -1.47 |
| Mar 31, 2025 | -1.34 |
| Dec 31, 2024 | -2.57 |
| Sep 30, 2024 | -1.06 |
| Jun 30, 2024 | -1.29 |
| Dec 31, 2023 | -55.93 |